Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Cerus Corp (CERS) AI Forecast

Our AI analyzed Cerus Corp. Create a free account to see the 90-day price prediction.

Free account • 30-day free trial

$CERS Neutral Signal Full forecast available

Cerus Corp (CERS) AI Stock Price Forecast & Investment Analysis

Cerus Corp Stock Price Chart and Technical Analysis

Loading chart...

Cerus Corp (CERS) - Comprehensive Stock Analysis & Investment Research

Deep dive into Cerus Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on May 27, 2026, 8:23 p.m. (UTC)

Cerus Corp Investment Summary

When evaluating whether Cerus Corp (CERS) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Cerus Corp (CERS) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $545 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Cerus Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Cerus Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Cerus Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Cerus Corp

Sign Up Free
Corporate Identity

Cerus Corp (Stock Symbol: CERS) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Cerus Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Cerus Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Cerus Corp...

Unlock Full Company Profile

Get complete details about Cerus Corp

Sign Up Free
Revenue & Growth Analysis

Cerus Corp generates annual revenues of $574 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Cerus Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Cerus Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Cerus Corp...

Unlock Financial Analysis

Get complete financial metrics for Cerus Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Cerus Corp's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Cerus Corp strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Cerus Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-1 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a 46.0% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.

Operating margin of -74.9% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 2.58x indicates exceptional efficiency in utilizing company assets to generate revenue. High asset turnover is characteristic of retail, distribution, or service businesses that operate with relatively lean asset bases. This efficiency translates to higher returns on invested capital when combined with reasonable margins.

Financial Strength & Leverage

Current ratio of 1.63 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.

Cerus Corp (CERS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Cerus Corp stock analysis.

Deep dive into Cerus Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Cerus Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Cerus Corp:

P/B Ratio 8.06x
Market Cap $545M
EPS $-0.96
Book Value/Share $0.35
Revenue/Share $2.96
FCF/Share $-0.01
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Cerus Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cerus Corp: An ROE of -67.1% indicates room for improvement in shareholder value creation.

ROE -67.1%
ROA -20.3%
ROIC -33.6%
Gross Margin 46.0%
Operating Margin -74.9%
Net Margin -87.5%
EBT Margin -74.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Cerus Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Cerus Corp: A current ratio of 1.63 shows adequate liquidity.

Current Ratio 1.63x
Quick Ratio 1.06x
D/E Ratio 2.29x
Financial Leverage 3.30x
Interest Coverage -0.1x
Working Capital $68M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Cerus Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Cerus Corp: Free cash flow of $-1M indicates cash challenges that need attention.

Operating Cash Flow -$44M
Free Cash Flow -$1M
Capital Spending $43M
FCF/Sales -0.2%
CapEx/Sales 7.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Cerus Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Cerus Corp: An asset turnover of 2.58x demonstrates efficient asset utilization.

Asset Turnover 2.58x
Receivables Turnover 19.6x
Inventory Turnover 0.5x
Fixed Assets Turnover 62.2x
Days Sales Outstanding 19 days
Days Inventory 751 days
Payables Period 391 days
Cash Conversion Cycle 379 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Cerus Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Cerus Corp: With annual revenue of $574M, Cerus Corp demonstrates solid business size.

Income Statement
Total Revenue $574M
Operating Income -$38M
Net Income -$45M
R&D Expense $8M
SG&A Expense $47M
Cost of Goods Sold $30M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 175%
Cash & Short-term Investments 28%
Total Liabilities 155%
Short-term Debt 76%
Accounts Receivable 29%
Inventory 61%
Dividend & Shareholder Information
Shares Outstanding 194M
Growth Metrics (YoY)
Net Income Growth -87.5%
EPS Growth -34.2%

Latest Cerus Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Cerus Corp (CERS) stock price and investment outlook.

source: Seeking Alpha

Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Cerus Corporation Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions]. Please be advised ...

More news available

Sign up free to read all 11 news articles and stay updated on market developments.

Sign Up Free to Read More

Cerus Corp Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Cerus Corp against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $17M x 3.0x
Aethlon Medical Inc AEMD ██% $4M x 0.7x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $11M x x
Autonomix Medical, Inc. AMIX ██% $5M x 0.5x
Angiodynamics Inc ANGO ██% $492M x 2.8x
Anika Therapeutics, Inc. ANIK ██% $199M x 1.5x
Artivion, Inc. AORT ██% $1.11B 95.4x 2.5x
Apyx Medical Corp APYX ██% $171M x 13.4x
Accuray Inc ARAY ██% $45M x 1.1x
Alphatec Holdings, Inc. ATEC ██% $1.20B x x
Atricure, Inc. ATRC ██% $1.39B x 2.8x
Nuo Therapeutics, Inc. AURX ██% $48M x x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $10.07B x 1.7x
Beta Bionics, Inc. BBNX ██% $522M x 1.9x
Becton Dickinson & Co BDX ██% $40.71B 35.8x 1.7x
Heartbeam, Inc. BEAT ██% $50M x 78.1x
Bluejay Diagnostics, Inc. BJDX ██% $2M x 0.5x
Boston Scientific Corp BSX ██% $85.59B 24.0x 3.3x
Biotricity Inc. BTCY ██% $4M x x
Bioventus Inc. BVS ██% $607M 21.3x 3.2x
Brainsway Ltd. BWAY ██% $620M x x
Carlsmed, Inc. CARL ██% $323M x 3.5x
Cerus Corp CERS ██% $545M x 8.1x
Clearpoint Neuro, Inc. CLPT ██% $339M x 18.0x
Co-Diagnostics, Inc. CODX ██% $33M x 2.1x
Cytosorbents Corp CTSO ██% $29M x 13.3x
Cvrx, Inc. CVRX ██% $161M x 5.5x
Delcath Systems, Inc. DCTH ██% $373M 665.3x 3.3x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $55M x 0.9x
Alpha Tau Medical Ltd. DRTS ██% $913M x 11.8x
Dexcom Inc DXCM ██% $27.79B 29.9x 9.4x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Dynatronics Corp DYNTQ ██% $0.00M x 0.0x
Ebr Systems, Inc. EBRCZ ██% $138M x 14.5x
Encision Inc ECIA ██% $3M x 1.8x
Embecta Corp. EMBC ██% $197M 1.8x x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $23M x 3.1x
Family Office Of America, Inc. FOFA ██% $36M 231.9x 37.6x
Glucotrack, Inc. GCTK ██% $4M x x
Global Innovative Platforms Inc. GIPL ██% $170K x 0.3x
Glaukos Corp GKOS ██% $6.46B x 9.6x
Globus Medical Inc GMED ██% $11.52B 19.6x 2.4x
Fractyl Health, Inc. GUTS ██% $146M x 6.8x
Haemonetics Corp HAE ██% $3.00B 30.9x 3.8x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $25M x 267.5x
Heartflow, Inc. HTFL ██% $2.52B x 8.8x
Integra Lifesciences Holdings Corp IART ██% $1.17B x 1.1x
Icecure Medical Ltd. ICCM ██% $18M x 2.0x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.37B 72.8x 1.6x
Interpace Biosciences, Inc. IDXG ██% $50M 2.1x 2.2x
Inspira Technologies Oxy B.H.N. Ltd IINN ██% $66M x 28.5x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $6M x 0.7x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.21B 9.2x 1.5x
Iradimed Corp IRMD ██% $1.19B 50.3x 12.1x
Irhythm Holdings, Inc. IRTC ██% $3.76B x 23.3x
Invo Fertility, Inc. IVF ██% $3M x 0.5x
Orthopediatrics Corp KIDS ██% $424M x 1.3x
Kestra Medical Technologies, Ltd. KMTS ██% $1.27B x 4.4x
Koru Medical Systems, Inc. KRMD ██% $194M x 11.5x
Lemaitre Vascular Inc LMAT ██% $2.26B 36.1x 5.6x
Lensar, Inc. LNSR ██% $71M 2.4x 6.6x
Lucid Diagnostics Inc. LUCD ██% $212M x 52.9x
Pulmonx Corp LUNG ██% $66M x 1.5x
Lyra Therapeutics, Inc. LYRA ██% $1M x x
Microbot Medical Inc. MBOT ██% $122M x 1.6x
Mountain Crest Acquisition Corp. V MCAG ██% $37M x x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $74M x x
Medline Inc. MDLN ██% $29.62B 35.4x 2.6x
Medinotec Inc. MDNC ██% $59M 25.1x 10.7x
Mimedx Group, Inc. MDXG ██% $534M 17.4x 2.2x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $80.34B 28.8x 24.6x
Merit Medical Systems Inc MMSI ██% $3.85B 27.6x 2.4x
Modular Medical, Inc. MODD ██% $27M x 4.5x
Nephros Inc NEPH ██% $39M 50.0x 3.6x
Neuroone Medical Technologies Corp NMTC ██% $33M x 6.2x
Neuropace Inc NPCE ██% $566M x 39.1x
Inspiremd, Inc. NSPR ██% $44M x 1.0x
Nu-Med Plus, Inc. NUMD ██% $850K x x
Novocure Ltd NVCR ██% $2.11B x 6.4x
Envveno Medical Corp NVNO ██% $7M x 0.3x
Nexgel, Inc. NXGL ██% $4M x 1.1x
Nyxoah Sa NYXH ██% $116M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $233M x 5.7x
Odyssey Health, Inc. ODYY ██% $2M x x
Orthofix Medical Inc. OFIX ██% $395M x 0.9x
Osr Holdings, Inc. OSRH ██% $16M x 0.2x
Orasure Technologies Inc OSUR ██% $284M x 0.9x
Pavmed Inc. PAVM ██% $45M x 1.1x
Pro Dex Inc PDEX ██% $204M 17.0x 4.5x
Penumbra Inc PEN ██% $12.60B 73.7x 8.6x
Petvivo Holdings, Inc. PETV ██% $27M x 8.1x
Profusa, Inc. PFSA ██% $2M x x
Polyrizon Ltd. PLRZ ██% $30M x 1.4x
Pulse Biosciences, Inc. PLSE ██% $1.77B x 26.8x
Picard Medical, Inc. PMI ██% $13M x x
Insulet Corp PODD ██% $10.76B 35.6x 8.3x
Procept Biorobotics Corp PRCT ██% $1.56B x 4.5x
Premier Air Charter Holdings Inc. PREM ██% $2M x 0.8x
Profound Medical Corp. PROF ██% $246M x 4.1x
Plus Therapeutics, Inc. PSTV ██% $45M x 3.8x
Polypid Ltd. PYPD ██% $87M x 7.9x
Avita Medical, Inc. RCEL ██% $131M x x
Vivos Inc RDGL ██% $34M x 12.5x
Resmed Inc RMD ██% $30.17B 19.9x 4.7x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $75M x x
Retractable Technologies Inc RVP ██% $21M x 0.3x
Sight Sciences, Inc. SGHT ██% $261M x 4.8x
Si-Bone, Inc. SIBN ██% $648M x 3.6x
Sigyn Therapeutics, Inc. SIGY ██% $60K x x
Sintx Technologies, Inc. SINT ██% $10M x 11.1x
Skinhealth Systems Inc. SKIN ██% $111M x 2.0x
Sonoma Pharmaceuticals, Inc. SNOA ██% $4M x 1.1x
Sanuwave Health, Inc. SNWV ██% $141M 8.8x 76.8x
Solventum Corp SOLV ██% $13.24B 9.2x 2.7x
Sensus Healthcare, Inc. SRTS ██% $53M x 1.2x
Ss Innovations International, Inc. SSII ██% $746M x 13.7x
Strata Skin Sciences, Inc. SSKN ██% $880K x 0.3x
Neuronetics, Inc. STIM ██% $85M x 6.4x
Stimcell Energetics Inc. STME ██% $6M x x
Sharps Technology Inc. STSS ██% $72M x 0.4x
Stevanato Group S.P.A. STVN ██% $4.91B x x
Stryker Corp SYK ██% $120.58B 36.1x 5.3x
Tactile Systems Technology Inc TCMD ██% $569M 28.0x 2.6x
Tela Bio, Inc. TELA ██% $36M x x
Teleflex Inc TFX ██% $5.84B x 1.9x
Trisalus Life Sciences, Inc. TLSI ██% $198M x 15.4x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $186M x 2.4x
Tandem Diabetes Care Inc TNDM ██% $1.00B x 7.6x
Tenon Medical, Inc. TNON ██% $8M x 4.2x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.75B 25.5x 4.0x
Qhslab, Inc. USAQ ██% $5M 11.6x 3.3x
Utah Medical Products Inc UTMD ██% $214M 19.7x 1.8x
Venus Concept Inc. VERO ██% $580K x 0.2x
Catheter Precision, Inc. VTAK ██% $2M x 0.3x
Vivos Therapeutics, Inc. VVOS ██% $10M x x
Vycor Medical Inc VYCO ██% $2M x x
West Pharmaceutical Services Inc WST ██% $21.98B 40.5x 7.4x
Beyond Air, Inc. XAIR ██% $6M x 0.7x
Xtant Medical Holdings, Inc. XTNT ██% $66M 36.1x 1.4x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Cerus Corp Stock Forecast

How accurate are Cerus Corp stock predictions?

Our AI model shows a 11% Spearman correlation coefficient for CERS predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Cerus Corp stock price forecasts?

Our analysis considers Cerus Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Cerus Corp a good investment in 2025?

Based on our AI analysis, Cerus Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Cerus Corp forecasts updated?

Cerus Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Cerus Corp?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...